Your Location:
Home >
Browse articles >
The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy
The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy
- “Advancements in single-cell and spatial transcriptomics have enabled a detailed molecular comprehension of the complex regulation of cell fate, significantly contributing to the development of personalized medicine. This review outlines the significance of single-cell RNA sequencing (scRNA-seq) in prostate cancer research, highlighting key molecular targets for diagnosis, treatment, and drug resistance characteristics. These studies are expected to provide novel insights for the development of immunotherapy and other innovative treatment strategies for castration-resistant prostate cancer.”
- Military Medical Research Vol. 12, Issue 2, Pages: 220-241(2025)
DOI: 10.1186/s40779-024-00526-7
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 4 ) Tabs( 2 )
References
Publication Info
Metrics
64
Views
31
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Crosstalk in the brain tumor microenvironment: mechanisms, therapeutic strategies, and clinical advances
Virtual medicine: medical AI in human health and diseases
Integrating artificial intelligence with human reasoning in oncology: questions on real-world implementation and patient-centric evidence
Leveraging artificial intelligence for clinical decision support in personalized standard regimen recommendation for cancer
Maladaptive reorganization of mediodorsal thalamus as a central mechanism in neuropathic pain-related sleep disorders
Related Author
Gui-Long Tanzhu
Liu Chen
Jiao-Yang Ning
Gang Xiao
Su Wen
Ce Wang
Hao Wen
Ke-Qin Zhang
Related Institution
Department of Oncology, Xiangya Hospital, Central South University
Department of Radiation Oncology, Hunan Cancer Hospital/Affiliated Hospital of Xiangya School of Medicine, Central South University
Key Laboratory of Translational Radiation Oncology, Department of Radiation Oncology, Hunan Cancer Hospital
Department of Radiology, China-Japan Friendship Hospital
Department of Nuclear Medicine, the Third Xiangya Hospital, Central South University

